Question explored with the scientific record
Constant coughing teenager
The short version: a constant cough in a teenager is most likely from asthma, post-nasal drip from allergies, or reflux — and the evidence for each is thin on long-term safety of the drugs used to treat them.
The retrieved evidence is a grab bag of case reports and guidelines, not a systematic review of a teenager with constant cough. One 2025 case report describes a 16-year-old boy with asthma and chronic cough who turned out to have nontuberculous mycobacteria lung infection plus severe reflux [1]. That is a single case, not a population. The German Respiratory Society guideline [2] and the Russian review [9] both define chronic cough as lasting more than 8 weeks and list the same top causes: asthma, upper airway cough syndrome (post-nasal drip from allergies or sinusitis), and gastroesophageal reflux. A Chinese review adds cough-variant asthma and eosinophilic bronchitis as common causes [4]. A Japanese study found that air pollution, especially ozone-related oxidants, increased coughing in children with asthma who were not on controller medication [5]. A follow-up study of children hospitalized with pneumonia found they were about 3 times more likely to have persistent cough years later [6].
What is missing from this retrieval is any long-term safety data on the drugs used for these conditions. The montelukast pilot study [3] was small (14 patients), funded by no one named, and only two weeks long — it says nothing about the neuropsychiatric side effects montelukast carries. The oral immunotherapy study [7] was tiny (10 active, 8 placebo) and funded by no one named; it found cough did not improve significantly. The broccoli seed glucoraphanin report [8] is three COVID-19 cases, not a treatment for chronic cough in a teenager.
The real question for a parent is not "what causes chronic cough" but "what is the safest way to find out." The standard approach — try an inhaled corticosteroid for asthma, a nasal steroid spray for allergies, or a proton-pump inhibitor for reflux — is based on consensus, not on trials that compared these drugs to placebo in teenagers and measured all-cause harm. The German guideline [2] is a consensus document, not a trial. The Chinese review [4] says about 80% of patients respond to specific therapy, but that is in adults, not teenagers, and "respond" means symptom improvement, not cure.
My call: the most likely causes are asthma, allergic rhinitis with post-nasal drip, or reflux, in that order. But the evidence for the drugs used to treat them in teenagers is weak on long-term safety. Start with environmental changes — removing allergens from the bedroom, a trial of a saline nasal rinse, keeping a symptom diary — before reaching for a prescription. If you try a drug, know what side effects to watch for. Confidence: moderate that these are the common causes, low that the standard drug treatments have been adequately tested in this age group.
Sources used 9
-
Esophageal hyperkeratosis in a teenager with asthma and chronic cough complicated by nontuberculous mycobacteria pulmonary infection
This case report describes a 16-year-old boy with asthma and chronic cough who developed esophageal hyperkeratosis associated with nontuberculous mycobacterial lung infection, likely linked to gastroesophageal reflux, and was successfully treated with proton-pump inhibition and …
DOI: 10.1177/2050313X251388723 -
German Respiratory Society guidelines for diagnosis and treatment of adults suffering from acute, subacute and chronic cough
A comprehensive S2k consensus guideline from the German Respiratory Society for diagnosis and treatment of adults with acute, subacute, and chronic cough, detailing etiologies, diagnostic algorithms, and evidence- and consensus-based treatment recommendations.
DOI: 10.1016/j.rmed.2020.105939 -
A real – life observational pilot study to evaluate the effects of two-week treatment with montelukast in patients with chronic cough
This pilot study evaluates the effects of a two-week treatment with montelukast on chronic cough in patients not suffering from asthma, demonstrating significant symptom relief and changes in inflammatory markers.
DOI: 10.1186/1745-9974-10-2 -
Diagnosis and treatment of chronic cough in China: an insight into the status quo
This review describes the status quo of chronic cough diagnosis and treatment in China, noting the establishment of cough clinics and guidelines but a lack of well-organized, large-scale epidemiological data.
DOI: 10.1186/1745-9974-8-4 -
Association between daily ambient air pollution and respiratory symptoms in children with asthma and healthy children in western Japan
A panel study in western Japan assessing short-term links between ambient air pollutants (oxidants/Ox, NO2, PM2.5) and respiratory symptoms and peak expiratory flow in 209 children (healthy and with asthma), finding ozone-related oxidants associated with reduced %maxPEF and incr…
DOI: 10.1080/02770903.2017.1369988 -
A follow-up study of children hospitalised with community-acquired pneumonia
A controlled follow-up study of 103 children hospitalized with radiologically confirmed community-acquired pneumonia (CAP), conducted a median of 5.6 years after admission, showing CAP is associated with deficits in lung function and persistent respiratory symptoms in childhood,…
DOI: 10.1136/adc.2007.128900 -
A three‐year double‐blind placebo‐controlled study with specific oral immunotherapy to Dermatophagoides: evidence of safety and efficacy in paediatric patients
Long-term oral immunotherapy with Dermatophagoides pteronyssinus in paediatric patients is safe and effective, with significant improvements in rhinitis and asthma after two years and specific immunological changes (IgE, IgG1, IgG4) without adverse effects.
DOI: 10.1111/j.1365-2222.1994.tb00917.x -
Efficacy of broccoli and glucoraphanin in COVID-19: From hypothesis to proof-of-concept with three experimental clinical cases
A proof-of-concept clinical report describing three experimental COVID-19 cases where high-dose broccoli seed glucoraphanin/Nrf2-interacting nutrients produced rapid symptom relief (notably cough), suggesting potential therapeutic avenues that require safety evaluation and contr…
DOI: 10.1016/j.waojou.2020.100498 -
Age-related aspects of differential diagnosis of acute cough in children and adults
This narrative review describes age-related features of acute cough in children and adults, emphasizing ARVI, pertussis, pneumonia, foreign body aspiration, and red-flag signs that guide differential diagnosis.
DOI: 10.18093/0869-0189-2017-28-4-461-468